全球传染病检测分子诊断市场:北美继续推动全球市场增长
市场调查报告书
商品编码
1158552

全球传染病检测分子诊断市场:北美继续推动全球市场增长

Market Study on Molecular Diagnostics in Infectious Disease Testing: North America to Continue Leading Global Market Growth

出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格

本报告研究和分析了全球传染病检测分子诊断市场,提供了 2022-2032 年预测期的市场概况、趋势、按细分市场和地区划分的市场分析、竞争格局和公司概况,并提供了系统信息。

内容

第 1 章执行摘要

第 2 章市场概述

  • 市场范围/分类
  • 市场定义/范围/限制

第 3 章主要市场趋势

  • 影响市场的主要趋势
  • 传染病检测分子诊断行业的未来展望
    • 增长动力
    • 品牌涌入
    • 创新的分销和营销策略

第四章规章制度

第五章传染病检测分子诊断全球市场需求分析及预测

  • 过去的市场分析
  • 当前和未来的市场预测
  • 同比增长率趋势分析

第 6 章全球传染病检测分子诊断市场:价格分析

  • 价格分析:按产品分类
  • 全球平均价格分析基准

第七章传染病检测分子诊断全球市场需求分析及预测

  • 过去的市场分析
  • 当前和未来的市场预测
    • 同比增长率趋势分析

第八章市场背景

  • 宏观经济因素
    • GDP 增长前景
    • 个人消费前景
    • GDP 增长分析
    • 收入人群概览
    • 人均可支配收入
  • 预测因素:相关性和影响
    • 主要公司的成长史
    • 城市化增长前景
    • 其他
  • 全球传染病检测分子诊断市场的 PESTLE 分析
  • 传染病检测分子诊断市场的投资可行性矩阵
  • 全球传染病检测分子诊断市场的波特五力分析
  • 市场动态
    • 司机
    • 约束因素
    • 机会分析

第 9 章传染病检测的全球分子诊断市场分析和预测:按产品分类

  • 简介/主要发现
  • 过去的市场分析:按产品分类
  • 当前和未来的市场分析和预测:按产品
    • 仪器和分析仪
    • 化验和试剂
    • 服务和软件
  • 市场吸引力分析:按产品

第 10 章传染病检测的全球分子诊断市场分析和预测:按应用

  • 简介/主要发现
  • 过去的市场分析:按应用
  • 当前和未来的市场分析和预测:按应用
    • 乙型肝炎
    • 丙型肝炎
    • 艾滋病
    • 肺结核
    • 耐甲氧西林金黄色葡萄球菌 (MRSA)
    • 院内感染
    • 沙眼衣原体和淋病奈瑟菌 (CT/NG)
    • 人乳头瘤病毒 (HPV) 感染
    • 其他
  • 市场吸引力分析:按应用

第 11 章全球传染病检测分子诊断市场分析和预测:按技术分类

  • 简介/主要发现
  • 历史市场和分析:按技术分类
  • 当前和未来的市场分析和预测:按技术分类
    • 聚合□炼式反应 (PCR)
    • 等温核酸扩增技术 (INAAT)
    • 微阵列
    • 下一代测序 (NGS)
    • 杂交
    • 其他
  • 市场吸引力分析:按技术

第 12 章传染病检测的全球分子诊断市场分析和预测:最终用户

  • 简介/主要发现
  • 过去的市场分析:按最终用户
  • 当前和未来的市场分析和预测:按最终用户分类
    • 医院
    • 私人实验室
    • 诊所
    • 学术机构
    • 实验室
    • 其他
  • 市场吸引力分析:按最终用户

第 13 章全球传染病检测分子诊断市场分析和预测:按地区

  • 介绍
  • 过去的市场分析:按地区
  • 当前市场分析和预测:按地区
    • 北美
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东和非洲 (MEA)
  • 市场吸引力分析:按地区

第十四章北美传染病检测分子诊断市场分析及预测

  • 介绍
  • 价格分析
  • 过去的市场和交易量趋势分析:按市场分类
  • 市场和数量预测:按市场分类
    • 按国家
    • 按产品分类
    • 最终用户
    • 通过使用
    • 按技术
  • 市场吸引力分析
    • 按国家
    • 按产品分类
    • 最终用户
    • 通过使用
    • 按技术

第 15 章拉丁美洲传染病检测分子诊断市场分析与预测

  • 介绍
  • 价格分析
  • 过去的市场和交易量趋势分析:按市场分类
  • 市场和数量预测:按市场分类
    • 按国家
    • 按产品分类
    • 最终用户
    • 通过使用
    • 按技术
  • 市场吸引力分析
    • 按国家
    • 按产品分类
    • 最终用户
    • 通过使用
    • 按技术

第十六章欧洲传染病检测分子诊断市场分析及预测

  • 介绍
  • 价格分析
  • 过去的市场和交易量趋势分析:按市场分类
  • 市场和数量预测:按市场分类
    • 按国家
    • 按产品分类
    • 最终用户
    • 通过使用
    • 按技术
  • 市场吸引力分析
    • 按国家
    • 按产品分类
    • 最终用户
    • 通过使用
    • 按技术

第十七章南亚传染病检测分子诊断市场分析及预测

  • 介绍
  • 价格分析
  • 过去的市场和交易量趋势分析:按市场分类
  • 市场和数量预测:按市场分类
    • 按国家
    • 按产品分类
    • 最终用户
    • 通过使用
    • 按技术
  • 市场吸引力分析
    • 按国家
    • 按产品分类
    • 最终用户
    • 通过使用
    • 按技术

第十八章东亚地区传染病检测分子诊断市场分析及预测

  • 介绍
  • 价格分析
  • 过去的市场和交易量趋势分析:按市场分类
  • 市场和数量预测:按市场分类
    • 按国家
    • 按产品分类
    • 最终用户
    • 通过使用
    • 按技术
  • 市场吸引力分析
    • 按国家
    • 按产品分类
    • 最终用户
    • 通过使用
    • 按技术

第十九章大洋洲传染病检测分子诊断市场分析及预测

  • 介绍
  • 价格分析
  • 过去的市场和交易量趋势分析:按市场分类
  • 市场和数量预测:按市场分类
    • 按国家
    • 按产品分类
    • 最终用户
    • 通过使用
    • 按技术
  • 市场吸引力分析
    • 按国家
    • 按产品分类
    • 最终用户
    • 通过使用
    • 按技术

第 20 章中东和非洲传染病检测分子诊断市场分析与预测

  • 介绍
  • 价格分析
  • 过去的市场和交易量趋势分析:按市场分类
  • 市场和数量预测:按市场分类
    • 按国家
    • 按产品分类
    • 最终用户
    • 通过使用
    • 按技术
  • 市场吸引力分析
    • 按国家
    • 按产品分类
    • 最终用户
    • 通过使用
    • 按技术

第21章主要国家传染病检测分子诊断市场分析

  • 介绍
    • 市值比率分析:主要国家
    • 全球和国家增长比较
  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 德国
  • 意大利
  • 英国
  • 中国
  • 日本
  • 韩国
  • 印度
  • 澳大利亚和新西兰
  • 南非

第22章市场结构分析

  • 市场分析:公司分层(传染病检测的分子诊断)
  • 市场集中度
  • 主要公司的市场份额分析
  • 市场占有率分析
    • 按公司地理分布
    • 产品足迹:按公司分类
    • 渠道足迹:按公司分类

第23章竞争分析

  • 比赛仪表板
  • 价格分析:按竞争对手
  • 竞争基准
  • 衝突详情
    • Abbott Laboratories
    • Becton
    • Dickinson and Company
    • bioMerieux
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd
    • Siemens AG
    • Veridex, LLC
    • Luminex Corp.
    • GenMark Diagnostics, Inc.
    • Qiagen N.V.
    • Genomix Biotech
    • bioTheranostics

第 24 章先决条件和使用的首字母缩略词

第 25 章研究方法论

Product Code: PMRREP4427

Report Scope:

Persistence Market Research recently published a new report on the molecular diagnostics in infectious disease testing market for the assessment period of 2022-2032. The report offers a close look at the evolving aspects of the market, and insights into the dynamics impacting market growth. It also focuses on key developments in the market, especially due to the COVID-19 pandemic situation that has affected people, globally. The report includes various macro- and micro-economic factors responsible for a significant impact on market growth.

The report on the molecular diagnostics in infectious disease testing market extensively focuses on the key trends shaping its growth. Additionally, the included opportunity analysis underlines untapped corners for aspiring players. The report also offers a holistic view of the incremental opportunity, which can further help readers make effective decisions for the growth of their businesses.

All stakeholders in the molecular diagnostics in infectious disease testing market can rely on the data offered in this report to make critical decisions. Moreover, the information offered in this report also can help new market entrants expand their bases in this space.

The report elaborates on both, historical and current trends shaping the molecular diagnostics in infectious disease testing market. The performance journey of the market has been drawn and analyzed to make the lucrative opportunities in the market evident to readers. The competitive landscape presented in the report gives a detailed outlook of the profiles of key companies manufacturing molecular diagnostics in infectious disease testing, along with their differential strategies and key focus areas.

Segmentation

The research study offers a detailed market taxonomy, wherein, key segments have been discussed in detail. The market is segmented on the basis of product, application, technique, end user, and region. Every segment is analyzed in detail, and data pertaining to the growth of each segment has been included in the study.

Product

  • Instruments and Analyzers
  • Assays and Reagents
  • Services and Software

Application

  • Hepatitis B
  • Hepatitis C
  • AIDS
  • Tuberculosis
  • Methicillin-Resistant Staphylococcus Aureus (MRSA)
  • Hospital-Acquired Infections
  • Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
  • Human Papillomavirus (HPV) Infection
  • Others

Technique

  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Microarrays
  • Next-Generation Sequencing (NGS)
  • Hybridization
  • Others

End User

  • Hospitals
  • Private Labs
  • Clinics
  • Academic Institutes
  • Laboratories
  • Others

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

The research report includes a competitive landscape that provides a dashboard view of the key competitors operating in the market. Some of the market players included in this section are Abbott Laboratories, Becton, Dickinson and Company, bioMerieux, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex Corp., GenMark Diagnostics, Inc., Qiagen N.V., Genomix Biotech, and bioTheranostics.

Key Questions Answered in Report

The research study on the manufacturing molecular diagnostics in infectious disease testing market offers inclusive insights about the growth of the market in the most comprehensive manner. Key insights offered in the report answer some of the most salient questions that assist stakeholders in gauging all the emerging possibilities.

  • Will the polymerase chain reaction (PCR) segment continue driving the sales of molecular diagnostics in infectious disease testing market?
  • How are technological developments aiding molecular diagnostics in infectious disease testing market?
  • Which region is a key contributor to the global molecular diagnostics in infectious disease testing market?

Research Methodology

A unique and promising research methodology forms the base of the market report for the forecast period. This report has been prepared after comprehensive analysis of market events, and riveting insights have been compiled meticulously.

The research methodology is a two-step process comprising primary and secondary research. Key stakeholders, including suppliers, service providers, and experts of several designations, including executive vice presidents, directors, technical advisors, GM marketing professionals, and sales professionals have been interviewed. Secondary sources referred to obtain information include investor presentations of manufacturers, World Bank, IMF, and other credible sources.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Overview
  • 1.2. Summary of Key Statistics
  • 1.3. Summary of Key Findings
  • 1.4. Product Evolution Analysis
  • 1.5. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage/Taxonomy
  • 2.2. Market Definition/Scope/Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Future Prospects of Molecular Diagnostics in Infectious Disease Testing Industry
    • 3.2.1. Factors Fuelling Growth
    • 3.2.2. Influx of Brands
    • 3.2.3. Innovative Distribution & Marketing Strategies

4. Rules and Regulations

  • 4.1. Warning Labels
  • 4.2. Regulatory Options for Little Cigars
    • 4.2.1. Product Description
    • 4.2.2. Health Risks
    • 4.2.3. End Usering
    • 4.2.4. Minimum Pack Technique Regulatory Gap
  • 4.3. Cigar Labeling and Warning Statement Requirements by FDA
  • 4.4. Tobacco Control Laws
    • 4.4.1. Use of E-Cigarettes is Prohibited
    • 4.4.2. Tobacco Advertising is Prohibited in Mass Media
    • 4.4.3. Others
  • 4.5. Others (During the Course of Study)

5. Global Molecular Diagnostics in Infectious Disease Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032

  • 5.1. Historical Market Volume ('000 Units) Analysis, 2017-2021
  • 5.2. Current and Future Market Volume ('000 Units) Projections, 2022-2032
  • 5.3. Y-o-Y Growth Trend Analysis

6. Global Molecular Diagnostics in Infectious Disease Testing Market - Pricing Analysis

  • 6.1. Pricing Analysis By Product
  • 6.2. Global Average Pricing Analysis Benchmark

7. Global Molecular Diagnostics in Infectious Disease Testing Market Demand (in Value or Technique in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Market Background

  • 8.1. Global Cigar industry Outlook
    • 8.1.1. Perception of Cigars
    • 8.1.2. Prevalence of Smoking Cigars among Adults
    • 8.1.3. Top 10 Cigars & Cigarillo Companies in the World
  • 8.2. Macro-Economic Factors
    • 8.2.1. GDP Growth Outlook
    • 8.2.2. Consumer Spending Outlook
    • 8.2.3. GDP Growth Rate Analysis
    • 8.2.4. Income Group Population Overview
    • 8.2.5. Per Capita Disposable Income
  • 8.3. Forecast Factors - Relevance & Impact
    • 8.3.1. Top Companies Historical Growth
    • 8.3.2. Urbanization Growth Outlook
    • 8.3.3. Others
  • 8.4. PESTLE Analysis of Global Molecular Diagnostics in Infectious Disease Testing Market
  • 8.5. Investment Feasibility Matrix of Molecular Diagnostics in Infectious Disease Testing Market
  • 8.6. Porter's Five Forces Analysis of Global Molecular Diagnostics in Infectious Disease Testing Market
  • 8.7. Market Dynamics
    • 8.7.1. Drivers
    • 8.7.2. Restraints
    • 8.7.3. Opportunity Analysis

9. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Product, 2017 - 2021
  • 9.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Product, 2022 - 2032
    • 9.3.1. Instruments and Analyzers
    • 9.3.2. Assays and Reagents
    • 9.3.3. Services and Software
  • 9.4. Market Attractiveness Analysis by Product

10. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Application, 2017 - 2021
  • 10.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Application, 2022 - 2032
    • 10.3.1. Hepatitis B
    • 10.3.2. Hepatitis C
    • 10.3.3. AIDS
    • 10.3.4. Tuberculosis
    • 10.3.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
    • 10.3.6. Hospital-Acquired Infections
    • 10.3.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
    • 10.3.8. Human Papillomavirus (HPV) Infection
    • 10.3.9. Others
  • 10.4. Market Attractiveness Analysis by Application

11. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Technique

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Technique, 2017 - 2021
  • 11.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Technique, 2022 - 2032
    • 11.3.1. Polymerase Chain Reaction (PCR)
    • 11.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 11.3.3. Microarrays
    • 11.3.4. Next-Generation Sequencing (NGS)
    • 11.3.5. Hybridization
    • 11.3.6. Others
  • 11.4. Market Attractiveness Analysis by Technique

12. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Flavor, 2017 - 2021
  • 12.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Flavor, 2022 - 2032
    • 12.3.1. Hospitals
    • 12.3.2. Private Labs
    • 12.3.3. Clinics
    • 12.3.4. Academic Institutes
    • 12.3.5. Laboratories
    • 12.3.6. Others
  • 12.4. Market Attractiveness Analysis by Flavor

13. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Region, 2017 - 2021
  • 13.3. Current Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Region, 2022 - 2032
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis by Region

14. North America Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
  • 14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
    • 14.4.1. By Country
      • 14.4.1.1. U.S.
      • 14.4.1.2. Canada
    • 14.4.2. By Product
    • 14.4.3. By End User
    • 14.4.4. By Application
    • 14.4.5. By Technique
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Product
    • 14.5.3. By End User
    • 14.5.4. By Application
    • 14.5.5. By Technique

15. Latin America Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
  • 15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
    • 15.4.1. By Country
      • 15.4.1.1. Brazil
      • 15.4.1.2. Mexico
      • 15.4.1.3. Rest of Latin America
    • 15.4.2. By Product
    • 15.4.3. By End User
    • 15.4.4. By Application
    • 15.4.5. By Technique
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Product
    • 15.5.3. By End User
    • 15.5.4. By Application
    • 15.5.5. By Technique

16. Europe Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
  • 16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
    • 16.4.1. By Country
      • 16.4.1.1. Germany
      • 16.4.1.2. Italy
      • 16.4.1.3. France
      • 16.4.1.4. U.K.
      • 16.4.1.5. Spain
      • 16.4.1.6. Rest of Europe
    • 16.4.2. By Product
    • 16.4.3. By End User
    • 16.4.4. By Application
    • 16.4.5. By Technique
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Product
    • 16.5.3. By End User
    • 16.5.4. By Application
    • 16.5.5. By Technique

17. South Asia Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
  • 17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
    • 17.4.1. By Country
      • 17.4.1.1. India
      • 17.4.1.2. Thailand
      • 17.4.1.3. Indonesia
      • 17.4.1.4. Malaysia
      • 17.4.1.5. Rest of South Asia
    • 17.4.2. By Product
    • 17.4.3. By End User
    • 17.4.4. By Application
    • 17.4.5. By Technique
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Product
    • 17.5.3. By End User
    • 17.5.4. By Application
    • 17.5.5. By Technique

18. East Asia Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
  • 18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
    • 18.4.1. By Country
      • 18.4.1.1. China
      • 18.4.1.2. Japan
      • 18.4.1.3. South Korea
    • 18.4.2. By Product
    • 18.4.3. By End User
    • 18.4.4. By Application
    • 18.4.5. By Technique
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Product
    • 18.5.3. By End User
    • 18.5.4. By Application
    • 18.5.5. By Technique

19. Oceania Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 19.1. Introduction
  • 19.2. Pricing Analysis
  • 19.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
  • 19.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
    • 19.4.1. By Country
      • 19.4.1.1. Australia
      • 19.4.1.2. New Zealand
    • 19.4.2. By Product
    • 19.4.3. By End User
    • 19.4.4. By Application
    • 19.4.5. By Technique
  • 19.5. Market Attractiveness Analysis
    • 19.5.1. By Country
    • 19.5.2. By Product
    • 19.5.3. By End User
    • 19.5.4. By Application
    • 19.5.5. By Technique

20. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 20.1. Introduction
  • 20.2. Pricing Analysis
  • 20.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
  • 20.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
    • 20.4.1. By Country
      • 20.4.1.1. GCC Countries
      • 20.4.1.2. Northern Africa
      • 20.4.1.3. South Africa
      • 20.4.1.4. Rest of Middle East and Africa
    • 20.4.2. By Product
    • 20.4.3. By End User
    • 20.4.4. By Application
    • 20.4.5. By Technique
  • 20.5. Market Attractiveness Analysis
    • 20.5.1. By Country
    • 20.5.2. By Product
    • 20.5.3. By End User
    • 20.5.4. By Application
    • 20.5.5. By Technique

21. Key Countries' Molecular Diagnostics in Infectious Disease Testing Market Analysis 2022-2032

  • 21.1. Introduction
    • 21.1.1. Market Value Proportion Analysis, By Key Countries
    • 21.1.2. Global Vs. Country Growth Comparison
  • 21.2. U.S. Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.2.1. By Product
    • 21.2.2. By End User
    • 21.2.3. By Application
    • 21.2.4. By Technique
  • 21.3. Canada Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.3.1. By Product
    • 21.3.2. By End User
    • 21.3.3. By Application
    • 21.3.4. By Technique
  • 21.4. Mexico Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.4.1. By Product
    • 21.4.2. By End User
    • 21.4.3. By Application
    • 21.4.4. By Technique
  • 21.5. Brazil Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.5.1. By Product
    • 21.5.2. By End User
    • 21.5.3. By Application
    • 21.5.4. By Technique
  • 21.6. Germany Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.6.1. By Product
    • 21.6.2. By End User
    • 21.6.3. By Application
    • 21.6.4. By Technique
  • 21.7. Italy Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.7.1. By Product
    • 21.7.2. By End User
    • 21.7.3. By Application
    • 21.7.4. By Technique
  • 21.8. U.K. Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.8.1. By Product
    • 21.8.2. By End User
    • 21.8.3. By Application
    • 21.8.4. By Technique
  • 21.9. China Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.9.1. By Product
    • 21.9.2. By End User
    • 21.9.3. By Application
    • 21.9.4. By Technique
  • 21.10. Japan Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.10.1. By Product
    • 21.10.2. By End User
    • 21.10.3. By Application
    • 21.10.4. By Technique
  • 21.11. S. Korea Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.11.1. By Product
    • 21.11.2. By End User
    • 21.11.3. By Application
    • 21.11.4. By Technique
  • 21.12. India Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.12.1. By Product
    • 21.12.2. By End User
    • 21.12.3. By Application
    • 21.12.4. By Technique
  • 21.13. Australia and New Zealand Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.13.1. By Product
    • 21.13.2. By End User
    • 21.13.3. By Application
    • 21.13.4. By Technique
  • 21.14. South Africa Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.14.1. By Product
    • 21.14.2. By End User
    • 21.14.3. By Application
    • 21.14.4. By Technique

22. Market Structure Analysis

  • 22.1. Market Analysis by Tier of Companies (Molecular Diagnostics in Infectious Disease Testing)
  • 22.2. Market Concentration
  • 22.3. Market Share Analysis of Top Players
  • 22.4. Market Presence Analysis
    • 22.4.1. By Regional footprint of Players
    • 22.4.2. Product foot print by Players
    • 22.4.3. Channel Foot Print by Players

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Pricing Analysis by Competition
  • 23.3. Competition Benchmarking
  • 23.4. Competition Deep Dive
    • 23.4.1. Abbott Laboratories
      • 23.4.1.1. Overview
      • 23.4.1.2. Product Portfolio
      • 23.4.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.1.4. Sales Footprint
      • 23.4.1.5. Strategy Overview
        • 23.4.1.5.1. Marketing Strategy
        • 23.4.1.5.2. Product Strategy
        • 23.4.1.5.3. Channel Strategy
    • 23.4.2. Becton
      • 23.4.2.1. Overview
      • 23.4.2.2. Product Portfolio
      • 23.4.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.2.4. Sales Footprint
      • 23.4.2.5. Strategy Overview
        • 23.4.2.5.1. Marketing Strategy
        • 23.4.2.5.2. Product Strategy
        • 23.4.2.5.3. Channel Strategy
    • 23.4.3. Dickinson and Company
      • 23.4.3.1. Overview
      • 23.4.3.2. Product Portfolio
      • 23.4.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.3.4. Sales Footprint
      • 23.4.3.5. Strategy Overview
        • 23.4.3.5.1. Marketing Strategy
        • 23.4.3.5.2. Product Strategy
        • 23.4.3.5.3. Channel Strategy
    • 23.4.4. bioMerieux
      • 23.4.4.1. Overview
      • 23.4.4.2. Product Portfolio
      • 23.4.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.4.4. Sales Footprint
      • 23.4.4.5. Strategy Overview
        • 23.4.4.5.1. Marketing Strategy
        • 23.4.4.5.2. Product Strategy
        • 23.4.4.5.3. Channel Strategy
    • 23.4.5. Thermo Fisher Scientific Inc.
      • 23.4.5.1. Overview
      • 23.4.5.2. Product Portfolio
      • 23.4.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.5.4. Sales Footprint
      • 23.4.5.5. Strategy Overview
        • 23.4.5.5.1. Marketing Strategy
        • 23.4.5.5.2. Product Strategy
        • 23.4.5.5.3. Channel Strategy
    • 23.4.6. F. Hoffmann-La Roche Ltd
      • 23.4.6.1. Overview
      • 23.4.6.2. Product Portfolio
      • 23.4.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.6.4. Sales Footprint
      • 23.4.6.5. Strategy Overview
        • 23.4.6.5.1. Marketing Strategy
        • 23.4.6.5.2. Product Strategy
        • 23.4.6.5.3. Channel Strategy
    • 23.4.7. Siemens AG
      • 23.4.7.1. Overview
      • 23.4.7.2. Product Portfolio
      • 23.4.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.7.4. Sales Footprint
      • 23.4.7.5. Strategy Overview
        • 23.4.7.5.1. Marketing Strategy
        • 23.4.7.5.2. Product Strategy
        • 23.4.7.5.3. Channel Strategy
    • 23.4.8. Veridex, LLC
      • 23.4.8.1. Overview
      • 23.4.8.2. Product Portfolio
      • 23.4.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.8.4. Sales Footprint
      • 23.4.8.5. Strategy Overview
        • 23.4.8.5.1. Marketing Strategy
        • 23.4.8.5.2. Product Strategy
        • 23.4.8.5.3. Channel Strategy
    • 23.4.9. Luminex Corp.
      • 23.4.9.1. Overview
      • 23.4.9.2. Product Portfolio
      • 23.4.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.9.4. Sales Footprint
      • 23.4.9.5. Strategy Overview
        • 23.4.9.5.1. Marketing Strategy
        • 23.4.9.5.2. Product Strategy
        • 23.4.9.5.3. Channel Strategy
    • 23.4.10. GenMark Diagnostics, Inc.
      • 23.4.10.1. Overview
      • 23.4.10.2. Product Portfolio
      • 23.4.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.10.4. Sales Footprint
      • 23.4.10.5. Strategy Overview
        • 23.4.10.5.1. Marketing Strategy
        • 23.4.10.5.2. Product Strategy
        • 23.4.10.5.3. Channel Strategy
    • 23.4.11. Qiagen N.V.
      • 23.4.11.1. Overview
      • 23.4.11.2. Product Portfolio
      • 23.4.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.11.4. Sales Footprint
      • 23.4.11.5. Strategy Overview
        • 23.4.11.5.1. Marketing Strategy
        • 23.4.11.5.2. Product Strategy
        • 23.4.11.5.3. Channel Strategy
    • 23.4.12. Genomix Biotech
      • 23.4.12.1. Overview
      • 23.4.12.2. Product Portfolio
      • 23.4.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.12.4. Sales Footprint
      • 23.4.12.5. Strategy Overview
        • 23.4.12.5.1. Marketing Strategy
        • 23.4.12.5.2. Product Strategy
        • 23.4.12.5.3. Channel Strategy
    • 23.4.13. bioTheranostics
      • 23.4.13.1. Overview
      • 23.4.13.2. Product Portfolio
      • 23.4.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.13.4. Sales Footprint
      • 23.4.13.5. Strategy Overview
        • 23.4.13.5.1. Marketing Strategy
        • 23.4.13.5.2. Product Strategy
        • 23.4.13.5.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

List of Tables

  • Table 1: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 2: Global Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 3: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 4: Global Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 5: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 6: Global Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 7: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 8: Global Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
  • Table 9: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Region, 2017-2032
  • Table 10: Global Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Region, 2017-2032
  • Table 11: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
  • Table 12: North America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
  • Table 13: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 14: North America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 15: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 16: North America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 17: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 18: North America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 19: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 20: North America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
  • Table 21: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
  • Table 22: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
  • Table 23: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 24: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 25: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 26: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 27: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 28: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 29: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 30: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
  • Table 31: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
  • Table 32: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
  • Table 33: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 34: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 35: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 36: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 37: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 38: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 39: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 40: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
  • Table 41: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
  • Table 42: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
  • Table 43: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 44: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 45: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 46: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 47: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 48: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 49: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 50: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
  • Table 51: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
  • Table 52: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
  • Table 53: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 54: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 55: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 56: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 57: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 58: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 59: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 60: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
  • Table 61: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
  • Table 62: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
  • Table 63: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 64: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 65: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 66: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 67: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 68: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 69: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 70: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
  • Table 71: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
  • Table 72: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
  • Table 73: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 74: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 75: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 76: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 77: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 78: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 79: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 80: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032

List of Figures

  • Figure 01: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) and Volume ('000 Units) Analysis, 2017-2021
  • Figure 02: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) and Volume ('000 Units) Forecast 2022-2032
  • Figure 03: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis, 2017-2021
  • Figure 04: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Forecast, 2022-2032
  • Figure 05: Global Molecular Diagnostics in Infectious Disease Testing Absolute $ Opportunity (US$ Mn) 2022-2032
  • Figure 06: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 07: Global Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 08: Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 09: Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 10: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 11: Global Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 12: Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 13: Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 14: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 15: Global Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
  • Figure 16: Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
  • Figure 17: Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 18: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 19: Global Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 20: Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 21: Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 22: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Region, 2017-2032
  • Figure 23: Global Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Region, 2017-2032
  • Figure 24: Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Region, 2022-2032
  • Figure 25: Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Region, 2022-2032
  • Figure 26: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 27: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
  • Figure 28: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
  • Figure 29: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 30: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 31: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 32: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 33: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 34: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 35: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 36: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 37: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 38: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 39: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
  • Figure 40: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
  • Figure 41: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 42: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 43: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 44: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 45: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 46: Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 47: Latin America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
  • Figure 48: Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
  • Figure 49: Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 50: Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 51: Latin America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 52: Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 53: Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 54: Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 55: Latin America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 56: Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 57: Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 58: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 59: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 60: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 61: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 62: Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 63: Latin America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 64: Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 65: Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 66: Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 67: Europe Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
  • Figure 68: Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
  • Figure 69: Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 70: Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 71: Europe Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 72: Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 73: Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 74: Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 75: Europe Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 76: Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 77: Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 78: Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 79: Europe Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
  • Figure 80: Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
  • Figure 81: Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 82: Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 83: Europe Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 84: Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 85: Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 86: East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 87: East Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
  • Figure 88: East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
  • Figure 89: East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 90: East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 91: East Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 92: East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 93: East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 94: East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 95: East Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 96: East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 97: East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 98: East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 99: East Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
  • Figure 100: East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
  • Figure 101: East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 102: East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 103: East Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 104: East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 105: East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 106: South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 107: South Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
  • Figure 108: South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
  • Figure 109: South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 110: South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 111: South Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 112: South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 113: South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 114: South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 115: South Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 116: South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 117: South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 118: South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 119: South Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
  • Figure 120: South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
  • Figure 121: South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 122: South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 123: South Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 124: South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 125: South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 126: Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 127: Oceania Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
  • Figure 128: Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
  • Figure 129: Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 130: Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 131: Oceania Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 132: Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 133: Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 134: Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 135: Oceania Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 136: Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 137: Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 138: Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 139: Oceania Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
  • Figure 140: Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
  • Figure 141: Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 142: Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 143: Oceania Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 144: Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 145: Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 146: MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 147: MEA Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
  • Figure 148: MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
  • Figure 149: MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 150: MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 151: MEA Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 152: MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 153: MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 154: MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 155: MEA Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 156: MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 157: MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 158: MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 159: MEA Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
  • Figure 160: MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
  • Figure 161: MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 162: MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 163: MEA Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 164: MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 165: MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032